Falk Workshop - Autoimmune Hepatitis and Overlap Syndromes -
East Meets West

Date:	15th February 2009 (Sunday)
Time:	14:00 - 16:30
Venue:	Theatre 2, HKCEC
Organizers:	Falk Foundation e.V.

 

Session 1

14:00 - 14:15	Introduction
14:15 - 14:45	Definition and differential diagnosis of autoimmune hepatitis in West and East
14:45 - 15:15	Autoantibodies and autoantigenes: Nomenclature and diagnostic value
15:15 - 15:45	Therapy of autoimmune hepatitis - Present and future
15:45	Coffee break

Session 2

16:15 - 16:45	Primary sclerosing cholangitis - Pathogenesis, malignancy and therapy
16:45 - 17:15	Primary biliary cirrhosis - Latest developments in pathogenesis and therapy
17:15 - 17:45	Overlap syndromes - Definition and therapy
17:45 - 18:15	The role of liver transplantation in autoimmune liver diseases
18:15	Concluding remarks

USJMS C P-NIH-APASL Joint Symposium -
HBV Antiviral Resistance

Date:	16th February 2009 (Monday)
Time:	08:30 - 17:00
Venue:	Theatre 2, HKCEC
Organizers:	US-Japan Medical Science Cooperative Program (USJMSCP) National Institute of Allergy and Infectious Diseases, National Institute of Health USA. (NIH) Asian Pacific Association for the Study of the Liver (APASL)
Course Directors:	Rajen Koshy, Bethesda, USA Seng-Gee Lim, Singapore Anna S.F. Lok, Ann Arbor, USA Masashi Mizokami, Nagoya, Japan

This symposium includes by experts in the field followed by abstract presentations on data related to HBV antiviral resistance in Asia, and a workshop with key leaders in Asia on strategies for controlling this problem and feasibility of a survey or database study.

 

Goals and Objectives:

• To promote awareness of HBV antiviral resistance among physicians in Asia
• To determine the practice patterns and magnitude of HBV antiviral resistance in Asia
• To develop strategies to control this problem and
• To establish a database for tracking HBV antiviral resistance in Asia

 

Session I - Overview

Moderators:

Rajen Koshy, Bethesda Stephen A. Locarnini, North Melbourne

08:30 - 08:35	Introduction Speaker: Rajen Koshy, Bethesda
08:35 - 08:50	Nomenclature, diagnosis (genotypic, phenotypic and clinical) Speaker: Jean-Michel Pawlotsky, Creteil
08:50 - 09:05	Prevention and treatment Speaker: Marc G. Ghany, Bethesda
09:05 - 09:20	Database for HBV antiviral resistance - objectives, what data to collect, how to implement? Speaker: Stephen A. Locarnini, North Melbourne
09:20 - 09:35	Overview of practices in Asia Speaker: Seng-Gee Lim, Singapore
09:35 - 09:50	Discussion
09:50 - 10:05	Break & Poster Session

 

Session II - Regional Practice and Data

Moderators:

Anna S.F. Lok, Ann Arbor Seng-Gee Lim, Singapore

No Reimbursement Regions

10:15 - 10:30	India , Pakistan and Bangladesh: key issues Speaker: Wasim Jafri, Karachi Contributors: Shiv K. Sarin, New Delhi Mobin Khan, Dhaka
10:30 - 10:45	Indonesia , Malaysia and Philippines: key issues Speaker: Laurentius A. Lesmana, Jakarta Contributors: Rosmawati Mohamed, Kuala Lumpur Jose D. Sollano, Manila
10:45 - 11.00	Issues in Indochina (Vietnam, Cambodia. Laos) and Thailand Speaker: Teerha Piratvisuth, Hai Yat Contributor: Pham-Hoang Phiet, Ho Chi Minh City
11.00 - 11:15	China : similarities and differences in practice in different provinces Speaker: Ji-Dong Jia, Beijing Contributors: Jin-Lin Hou, Guangzhou Guang-Bi Yao, Shanghai

Partial Reimbursement Regions

11:15 - 11:30	Hong Kong and Taiwan: Differences and similarities of partial reimbursement systems. Do they work? Speaker: Henry L.Y. Chan, Hong Kong Contributor: Jia-Horng Kao, Taipei
11:30 - 11:45	Korea and Singapore Speaker: Kwang-Hyub Han, Seoul Contributor: Wan-Cheng Chow, Singapore

Full Reimbursement Regions

11:45 - 12:00	Japan Speaker: Masashi Mizokami, Nagoya
12:00 - 12:15	Australia and New Zealand Speaker: Edward J. Gane, Auckland Contributor: Geoffrey W. McCaughan, Sydney
12:15 - 13:00	Round Table Discussion
13:00 - 13:45	Lunch break and Poster Session

 

Session III - Free Paper Presentation

Moderators:

Masashi Mizokami, Nagoya Henry L.Y. Chan, Hong Kong

13:50 - 15:20

Oral Presentation (9 Presentations, 8+2 mins each)